Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Patient With CKD Develops Cholestatic Liver Injury During a Clinical Trial.
Wagener EDA, Souma N, Hodakowski A, Martinez C, Fox P, Mehta R, O'Brien MJ, Bolon M, Kulik L, Yang GY, Isakova T; CKD Optimal Management with Binders and NicotinamidE (COMBINE) Investigators. Wagener EDA, et al. Kidney Int Rep. 2017 Jul 29;3(1):5-10. doi: 10.1016/j.ekir.2017.07.012. eCollection 2018 Jan. Kidney Int Rep. 2017. PMID: 29340307 Free PMC article. No abstract available.
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.
Appel LJ, Wright JT Jr, Greene T, Kusek JW, Lewis JB, Wang X, Lipkowitz MS, Norris KC, Bakris GL, Rahman M, Contreras G, Rostand SG, Kopple JD, Gabbai FB, Schulman GI, Gassman JJ, Charleston J, Agodoa LY; African American Study of Kidney Disease and Hypertension Collaborative Research Group. Appel LJ, et al. Among authors: gassman jj. Arch Intern Med. 2008 Apr 28;168(8):832-9. doi: 10.1001/archinte.168.8.832. Arch Intern Med. 2008. PMID: 18443258 Free PMC article. Clinical Trial.
Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy.
Weinberg JM, Appel LJ, Bakris G, Gassman JJ, Greene T, Kendrick CA, Wang X, Lash J, Lewis JA, Pogue V, Thornley-Brown D, Phillips RA; African American Study of Hypertension and Kidney Disease Collaborative Research Group. Weinberg JM, et al. Among authors: gassman jj. Arch Intern Med. 2009 Sep 28;169(17):1587-94. doi: 10.1001/archinternmed.2009.284. Arch Intern Med. 2009. PMID: 19786678 Clinical Trial.
Intensive blood-pressure control in hypertensive chronic kidney disease.
Appel LJ, Wright JT Jr, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X; AASK Collaborative Research Group. Appel LJ, et al. Among authors: gassman jj. N Engl J Med. 2010 Sep 2;363(10):918-29. doi: 10.1056/NEJMoa0910975. N Engl J Med. 2010. PMID: 20818902 Free PMC article. Clinical Trial.
Elevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease.
Fischer MJ, Kimmel PL, Greene T, Gassman JJ, Wang X, Brooks DH, Charleston J, Dowie D, Thornley-Brown D, Cooper LA, Bruce MA, Kusek JW, Norris KC, Lash JP; AASK Study Group. Fischer MJ, et al. Among authors: gassman jj. Kidney Int. 2011 Sep;80(6):670-8. doi: 10.1038/ki.2011.153. Epub 2011 Jun 1. Kidney Int. 2011. PMID: 21633409 Free PMC article.
Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial.
Kopp JB, Winkler CA, Zhao X, Radeva MK, Gassman JJ, D'Agati VD, Nast CC, Wei C, Reiser J, Guay-Woodford LM, Pollak MR, Hildebrandt F, Moxey-Mims M, Gipson DS, Trachtman H, Friedman AL, Kaskel FJ; FSGS-CT Study Consortium. Kopp JB, et al. Among authors: gassman jj. J Am Soc Nephrol. 2015 Jun;26(6):1443-8. doi: 10.1681/ASN.2013111242. Epub 2015 Jan 8. J Am Soc Nephrol. 2015. PMID: 25573908 Free PMC article. Clinical Trial.
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.
Isakova T, Ix JH, Sprague SM, Raphael KL, Fried L, Gassman JJ, Raj D, Cheung AK, Kusek JW, Flessner MF, Wolf M, Block GA. Isakova T, et al. Among authors: gassman jj. J Am Soc Nephrol. 2015 Oct;26(10):2328-39. doi: 10.1681/ASN.2015020117. Epub 2015 May 12. J Am Soc Nephrol. 2015. PMID: 25967123 Free PMC article. Review.
57 results